{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:20:33Z","timestamp":1790958033080,"version":"4.1.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100004530","name":"Universiti Putra Malaysia","doi-asserted-by":"publisher","award":["04-02-12-1762RU"],"award-info":[{"award-number":["04-02-12-1762RU"]}],"id":[{"id":"10.13039\/501100004530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>This study was aimed to investigate the potential of formulated valproic acid-encapsulated nanoemulsion (VANE) to improve the brain bioavailability of valproic acid (VPA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Valproic acid-encapsulated nanoemulsions were formulated and physically characterised (osmolarity, viscosity, drug content, drug encapsulation efficiency). Further investigations were also conducted to estimate the drug release, cytotoxic profile, in-vitro blood\u2013brain barrier (BBB) permeability, pharmacokinetic parameter and the concentration of VPA and VANE in blood and brain.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key findings<\/jats:title><jats:p>Physical characterisation confirmed that VANE was suitable for parenteral administration. Formulating VPA into nanoemulsion significantly reduced the cytotoxicity of VPA. In-vitro drug permeation suggested that VANEs crossed the BBB as freely as VPA. Pharmacokinetic parameters of VANE-treated rats in plasma and brain showed F3 VANE had a remarkable improvement in AUC, prolongation of half-life and reduction in clearance compared to VPA. Given the same extent of in-vitro BBB permeation of VPA and VANE, the higher bioavailability of VANE in brain was believed to have due to higher concentration of VANE in blood. The brain bioavailability of VPA was improved by prolonging the half-life of VPA by encapsulating it within the nanoemulsion-T80.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Nanoemulsion containing VPA has alleviated the cytotoxic effect of VPA and improved the plasma and brain bioavailability for parenteral delivery of VPA.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jphp.12800","type":"journal-article","created":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T10:14:40Z","timestamp":1502792080000},"page":"1447-1457","source":"Crossref","is-referenced-by-count":22,"title":["Characterisation, in-vitro and in-vivo evaluation of valproic acid-loaded nanoemulsion for improved brain bioavailability"],"prefix":"10.1093","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7777-5961","authenticated-orcid":false,"given":"Suk Fei","family":"Tan","sequence":"first","affiliation":[{"name":"Neuroscience Cluster, Department of Medicine, Faculty of Medicine and Health Sciences, University Putra Malaysia , Serdang, Selangor,","place":["Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P","family":"Kirby","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Royal College of Surgeons in Ireland , Dublin 2,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnson","family":"Stanslas","sequence":"additional","affiliation":[{"name":"Pharmacotherapeutic Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University Putra Malaysia , Serdang, Selangor,","place":["Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidon Bin","family":"Basri","sequence":"additional","affiliation":[{"name":"Neuroscience Cluster, Department of Medicine, Faculty of Medicine and Health Sciences, University Putra Malaysia , Serdang, Selangor,","place":["Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"2024103013044225900_jphp12800-cit-0001","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2710.2005.00671.x","article-title":"Valproate: a simple chemical with so much to offer","volume":"30","author":"Peterson","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"2024103013044225900_jphp12800-cit-0002","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5698\/1535-7511-12.5.199","article-title":"Targeting anti-epileptic drug therapy without collateral damage: nanocarrier-based drug delivery","volume":"12","author":"Rossi","year":"2012","journal-title":"Epilepsy Curr"},{"key":"2024103013044225900_jphp12800-cit-0003","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0090-9556(24)15355-X","article-title":"Disposition of valproic acid in maternal, fetal, and newborn sheep II: metabolism and renal elimination","volume":"28","author":"Kumar","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"2024103013044225900_jphp12800-cit-0004","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/tx00047a006","article-title":"Fluorinated analogs as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status","volume":"8","author":"Tang","year":"1995","journal-title":"Chem Res Toxicol"},{"key":"2024103013044225900_jphp12800-cit-0005","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1089\/ars.2009.2695","article-title":"Mitochondrial glutathione, a key survival antioxidant","volume":"11","author":"Mar\u00ed","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"2024103013044225900_jphp12800-cit-0006","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int J Pharm"},{"key":"2024103013044225900_jphp12800-cit-0007","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0378-5173(90)90047-8","article-title":"Modification of the body distribution of poly (methyl methacrylate) nanoparticles in rats by coating with surfactants","volume":"61","author":"Troster","year":"1990","journal-title":"Int J Pharm"},{"key":"2024103013044225900_jphp12800-cit-0008","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1166\/jnn.2003.077","article-title":"Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain","volume":"4","author":"Kreuter","year":"2004","journal-title":"J Nanosci Nanotechnol"},{"key":"2024103013044225900_jphp12800-cit-0009","first-page":"363","article-title":"Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers. In vivo pharmacodynamic studies using rat electroshock model","volume":"6","author":"Eskandari","year":"2011","journal-title":"Int J Nanomed"},{"key":"2024103013044225900_jphp12800-cit-0010","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/jps.22395","article-title":"Encapsulation of valproate-loaded hydrogel nanoparticles in human erythrocytes","volume":"100","author":"Hamidi","year":"2011","journal-title":"J Pharm Sci"},{"key":"2024103013044225900_jphp12800-cit-0011","first-page":"1","article-title":"Nanoemulsions for drug delivery through different routes","volume":"2","author":"Ravi","year":"2011","journal-title":"Res Biotechnol"},{"key":"2024103013044225900_jphp12800-cit-0012","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2217\/nnm.11.46","article-title":"In vivo real-time fluorescence visualization and brain-targeting mechanisms of lipid nanocarriers with different fatty ester:oil ratios","volume":"6","author":"Wen","year":"2011","journal-title":"Nanomedicine"},{"key":"2024103013044225900_jphp12800-cit-0013","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1111\/bph.12604","article-title":"Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling","volume":"171","author":"Moss","year":"2014","journal-title":"Br J Pharmacol"},{"key":"2024103013044225900_jphp12800-cit-0014","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jfoodeng.2008.12.002","article-title":"Extraction of safflower seed oil by supercritical CO2","volume":"92","author":"Han","year":"2009","journal-title":"J Food Eng"},{"key":"2024103013044225900_jphp12800-cit-0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12031-007-0050-3","article-title":"A model for fatty acid transport into the brain","volume":"33","author":"Hamilton","year":"2007","journal-title":"J Mol Neurosci"},{"key":"2024103013044225900_jphp12800-cit-0016","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ultsonch.2015.09.015","article-title":"Ultrasonic emulsification of parenteral valproic acid-loaded nanoemulsion with response surface methodology, evaluation of its stability","volume":"29","author":"Tan","year":"2016","journal-title":"Ultrason Sonochem"},{"key":"2024103013044225900_jphp12800-cit-0017","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijpharm.2012.01.011","article-title":"In vitro and in vivo evaluation of a simple microemulsion formulation for propofol","volume":"425","author":"Li","year":"2012","journal-title":"Int J Pharm"},{"key":"2024103013044225900_jphp12800-cit-0018","first-page":"1","article-title":"Poly(hydroxyalkanoates)-based polymeric nanoparticles for drug delivery","volume":"2009","author":"Errico","year":"2009","journal-title":"J Biomed Biotechnol"},{"key":"2024103013044225900_jphp12800-cit-0019","first-page":"670","article-title":"In vitro screening of alcohol-induced dose dumping phenomena for controlled released tramadol tablets","volume":"63","author":"Dragomiroiu","year":"2015","journal-title":"Farmacia"},{"key":"2024103013044225900_jphp12800-cit-0020","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","article-title":"Blood-brain barrier-specific properties of a human adult brain endothelial cell line","volume":"19","author":"Weksler","year":"2005","journal-title":"FASEB J"},{"key":"2024103013044225900_jphp12800-cit-0021","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jneumeth.2011.05.012","article-title":"Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models","volume":"199","author":"Hatherell","year":"2011","journal-title":"J Neurosci Methods"},{"key":"2024103013044225900_jphp12800-cit-0022","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-4159.2008.05730.x","article-title":"The human brain endothelial cell line hCMEC\/D3 as a human blood-brain barrier model for drug transport studies","volume":"107","author":"Poller","year":"2008","journal-title":"J Neurochem"},{"key":"2024103013044225900_jphp12800-cit-0023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0773.1992.tb00512.x","article-title":"Recent developments in peptide drug delivery to the brain","volume":"71","author":"Pardridge","year":"1992","journal-title":"Pharmacol Toxicol"},{"key":"2024103013044225900_jphp12800-cit-0024","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10611860903244199","article-title":"Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion","volume":"18","author":"Ganta","year":"2010","journal-title":"J Drug Target"},{"key":"2024103013044225900_jphp12800-cit-0025","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jchromb.2005.11.028","article-title":"Development and validation of a sensitive assay of valproic acid in human plasma by high-performance liquid chromatography without prior derivatization","volume":"830","author":"Amini","year":"2006","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2024103013044225900_jphp12800-cit-0026","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0928-0987(99)00059-7","article-title":"In vitro investigation of the effect of various isotonic substances in parenteral emulsions on human erythrocytes","volume":"9","author":"Jumaa","year":"1999","journal-title":"Eur J Pharm Sci"},{"key":"2024103013044225900_jphp12800-cit-0027","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/bja\/66.2.189","article-title":"Pain on i.v. injection of some anaesthetic agents is evoked by the unphysiological osmolality or pH of their formulations","volume":"66","author":"Klement","year":"1991","journal-title":"Br J Anaesth"},{"key":"2024103013044225900_jphp12800-cit-0028","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-5173(03)00364-8","article-title":"Systematic characterization of oil-in-water emulsions for formulation design","volume":"263","author":"Roland","year":"2003","journal-title":"Int J Pharm"},{"key":"2024103013044225900_jphp12800-cit-0029","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0378-5173(94)00355-9","article-title":"An Investigation of the effects of some process variables on the microencapsulation of propranolol hydrochloride by the solvent evaporation method","volume":"118","author":"Jones","year":"1995","journal-title":"Int J Pharm"},{"key":"2024103013044225900_jphp12800-cit-0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"2024103013044225900_jphp12800-cit-0031","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ultras.2008.04.009","article-title":"Acoustically active perfluorocarbon nanoemulsions as drug delivery carriers for camptothecin: drug release and cytotoxicity against cancer cells","volume":"49","author":"Fang","year":"2009","journal-title":"Ultrasonics"},{"key":"2024103013044225900_jphp12800-cit-0032","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol Pharm"},{"key":"2024103013044225900_jphp12800-cit-0033","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.apsb.2013.08.001","article-title":"Tween 80 containing lipid nanoemulsions for delivery of indinavir to brain","volume":"3","author":"Prabhakar","year":"2013","journal-title":"Acta Pharm Sin B"},{"key":"2024103013044225900_jphp12800-cit-0034","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijpharm.2006.11.016","article-title":"The effect of oil components on the physicochemical properties and drug delivery of emulsions: tocol emulsion versus lipid emulsion","volume":"335","author":"Hung","year":"2007","journal-title":"Int J Pharm"},{"key":"2024103013044225900_jphp12800-cit-0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijpharm.2013.10.055","article-title":"Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform","volume":"460","author":"Choudhury","year":"2014","journal-title":"Int J Pharm"},{"key":"2024103013044225900_jphp12800-cit-0036","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jps.21850","article-title":"Studies on controlled release of hydrophilic drugs from W\/O high internal phase ratio emulsions","volume":"99","author":"Calder\u00f3","year":"2010","journal-title":"J Pharm Sci"},{"key":"2024103013044225900_jphp12800-cit-0037","doi-asserted-by":"crossref","first-page":"623139","DOI":"10.5402\/2012\/623139","article-title":"Designing Paclitaxel drug delivery systems aimed at improved patient outcomes: current status and challenges","volume":"2012","author":"Surapaneni","year":"2012","journal-title":"ISRN Pharmacol"},{"key":"2024103013044225900_jphp12800-cit-0038","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1089\/vbz.2011.0948","article-title":"Nanospheres encapsulating anti-leishmanial drugs for their specific macrophage targeting, reduced toxicity, and deliberate intracellular release","volume":"12","author":"Shukla","year":"2012","journal-title":"Vector Borne Zoonotic Dis"},{"key":"2024103013044225900_jphp12800-cit-0039","volume-title":"ISO 10993-5:2009 Biological Evaluation of Medical Devices","author":"International Organization for Standardization"},{"key":"2024103013044225900_jphp12800-cit-0040","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ijpharm.2012.02.025","article-title":"Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice","volume":"427","author":"Ragelle","year":"2012","journal-title":"Int J Pharm"},{"key":"2024103013044225900_jphp12800-cit-0041","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s002800050451","article-title":"Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor EL and Tween 80","volume":"38","author":"Ellis","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"key":"2024103013044225900_jphp12800-cit-0042","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2007.07.013","article-title":"A lipid microsphere vehicle for vinorelbine: stability, safety and pharmacokinetics","volume":"348","author":"Zhang","year":"2008","journal-title":"Int J Pharm"},{"key":"2024103013044225900_jphp12800-cit-0043","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0899-9007(96)00089-6","article-title":"Parenteral use of medium-chain triglycerides: a reappraisal","volume":"12","author":"Ulrich","year":"1996","journal-title":"Nutrition"},{"key":"2024103013044225900_jphp12800-cit-0044","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1023\/A:1018983904537","article-title":"Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles","volume":"16","author":"Gulyaev","year":"1999","journal-title":"Pharm Res"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjphp.12800","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/69\/11\/1447\/60232752\/jphp12800.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/69\/11\/1447\/60232752\/jphp12800.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T22:53:35Z","timestamp":1750805615000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/69\/11\/1447\/6127872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,1]]},"published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jphp.12800","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11]]},"published":{"date-parts":[[2017,11,1]]}}}